SCHEMBL4669022

SCHEMBL4669022

CCOC(=O)C1=C(C)N=c2sc(=Cc3ccc(OC(C)=O)c(OC(C)=O)c3)c(=O)n2C1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.65
CSNK2B P67870 2/20 0.65
CSNK2A1 P68400 2/20 0.65
DNMT1 P26358 2/20 0.64
PSMD14 O00487 1/20 0.64
ALDH1A1 P00352 2/20 0.63
NPSR1 Q6W5P4 2/20 0.63
MEN1 O00255 8/20 0.61
KMT2A Q03164 8/20 0.61
MAPT P10636 2/20 0.61
GAA P10253 1/20 0.61
MMP14 P50281 1/20 0.61
CDC25B P30305 2/20 0.60
PTPN22 Q9Y2R2 5/20 0.59
PTPN7 P35236 3/20 0.59
DUSP3 P51452 3/20 0.59
PTPN12 Q05209 2/20 0.59
POLB P06746 2/20 0.59
BLM P54132 1/20 0.59
CACNA1B Q00975 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669020 1.00 CSNK2A2 (0.65) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4669054 0.90 ALDH1A1 (0.78) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4669050 0.90 ALDH1A1 (0.78) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4669053 0.89 DNMT1 (0.74) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4669049 0.89 DNMT1 (0.74) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4670366 0.88 MEN1 (0.74) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4670363 0.88 MEN1 (0.74) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4667556 0.87 CDC25B (0.80) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL4667559 0.87 CDC25B (0.80) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14
SCHEMBL14001087 0.87 CDC25B (0.74) CSNK2A2CSNK2BCSNK2A1DNMT1PSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000140-A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-10 EP disclosed